Expiration date: 06/2025
Action:
improves microcirculation and capillary permeability, normalizes pressure of endolymph in the labyrinth and the cochlea, increases the blood flow in the basilar artery, and normalizes conductivity in the neurons of the vestibular nuclei at the level of brain stem Lowers the frequency and intensity of dizziness, reduces the noise in the ears, improves hearing during its decline. Stable therapeutic effect occurs after 14 days.
Composition:
Betagistin dihydrochloride 8, 16 or 24 mg
Auxiliary substances: lactose monohydrate, MCC, potato starch, copovidone, carboximetilkrahmal sodium, silica colloidal anhydrous, magnesium stearate
Indications:
Treatment and prevention of vestibular vertigo of various etiology. Syndromes, including vertigo and headache, noise in the ears, progressive hearing loss, nausea, vomiting. Disease and Meniere's syndrome.
